In the News

By Denise Baez NEW YORK -- October 15, 2020 -- Patients with autoimmune diseases appear to have an increased risk of coronavirus disease 2019 (COVID-19), primarily attributed to glucocorticoid use, although their clinical outcomes were not considerably worse when compared with individuals without...
The US Food and Drug Administration (FDA) approved burosumab-twza (Crysvita) injection to treat patients aged 2 years and older with tumour-induced osteomalacia (TIO). “Treatment for TIO focuses on identifying and removing the tumour that causes the disease; however, when that is not possible, [...
The US Food and Drug Administration (FDA) has approved canakinumab (Ilaris) injection for the treatment of active Still’s Disease, including adult-onset Still’s Disease (AOSD). “Prior to today’s approval, patients had no FDA-approved treatments for their disease, which can include symptoms such as...
The percentage of patients with hip osteoarthritis who had a hip replacement within 2 years of hip arthroscopy was unacceptably high at 68%, according to a study of more than 2,600 patients published in HIP International. Within 2 years of having had arthroscopy, about two-thirds of patients with...
Women with breast cancer treated with tamoxifen or aromatase inhibitors did not have an increased risk of rheumatoid arthritis (RA) compared with women with breast cancer who did not take either therapy, according to a study published in the Annals of the Rheumatic Diseases. Using nationwide...

Conference Reports

By Eric Ramos

CHICAGO -- June 12, 2020 -- An intra-articular injection of JTA-004, a novel enhanced protein solution that is supplemented with hyaluronic acid and clonidine, improved pain in patients with knee osteoarthritis, according to a study presented at the 2020 Virtual Meeting of...

By Eric Ramos

CHICAGO -- June 11, 2020 -- A set of antibody biomarkers can help predict which patients with rheumatoid arthritis (RA) will respond to therapy, according to a study presented at the 2020 Virtual Meeting of the European League Against Rheumatism (EULAR).

“For...

By Eric Ramos

CHICAGO -- June 9, 2020 -- Long-term treatment with canakinumab was safe and effective for patients with colchicine-resistant familial Mediterranean fever, according to a study presented at the 2020 Virtual Meeting of the European League Against Rheumatism (EULAR).

“...

By Eric Ramos

CHICAGO -- June 9, 2020 -- Therapeutic drug monitoring in patients with rheumatic diseases who are starting treatment with infliximab does not appear to be superior to standard treatment in order to achieve remission, according to a study presented at the 2020 Virtual...

By Eric Ramos

CHICAGO -- June 8, 2020 -- Colchicine 1 mg/day for 12 weeks was not effective in improving pain, tender and swollen joint count, or grip strength in patients with symptomatic hand osteoarthritis, according to a study presented at the 2020 Virtual Meeting of the European...

Recently Published

Chinese Journal of Reparative and Reconstructive Surgery
Wei Zhang, Haiyang Yu, Hongliang Wang, Yunlei Zhai, Lei Dong, Guohui Zheng, Wenqiang Xu, Xu Zhang
Lupus
Simo Kariniemi, Vappu Rantalaiho, Lauri J Virta, Kari Puolakka, Tuulikki Sokka-Isler, Pia Elfving
New England Journal of Medicine (NEJM)
Andrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, Boulos Haraoui, Maureen Rischmueller, Nasser Khan, Ying Zhang, Naomi Martin, Ricardo M Xavier
Spine
Michael W Fields, Nathan J Lee, Daniel Y Hong, Ashok Para, Venkat Boddapati, Justin Mathew, Jun S Kim, Joseph Lombardi, Ronald A Lehman, K Daniel Riew
Spine
Qichang Gao, Zhizhuang Zhang, Tuo Shao, Weilong Tang, Yuhang Hu, Hongtao Sheng, Jiaao Gu, Zhange Yu

Full-Text Articles

Arthritis Research & Therapy
Mingjiao Zhang, Hongyu Jie, Yong Wu, Xinai Han, Xing Li, Yi He, Xingliang Shi, Yuwei Luo, Ying Sun, Jinlong Yang, Jing Yang, Shulv Quan, Xiaobin Lao, Liping Tan, Erwei Sun
Arthritis Research & Therapy
Serena Colafrancesco, Marta Vomero, Valentina Iannizzotto, Antonina Minniti, Cristiana Barbati, Francesca Arienzo, Linda Mastromanno, Tania Colasanti, Raffaella Izzo, Saba Nayar, Elena Pipi, Bruna Cerbelli, Carla Giordano, Francesco Ciccia, Fabrizio Conti, Guido Valesini, Francesca Barone, Roberta Priori, Cristiano Alessandri
Arthritis Research & Therapy
Ken-Ei Sada, Keiji Ohashi, Yosuke Asano, Keigo Hayashi, Michiko Morishita, Haruki Watanabe, Yoshinori Matsumoto, Shouichi Fujimoto, Yoshinari Takasaki, Kunihiro Yamagata, Shogo Banno, Hiroaki Dobashi, Koichi Amano, Masayoshi Harigai, Yoshihiro Arimura, Hirofumi Makino, Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan
Arthritis Research & Therapy
Christian S Thudium, Anne C Bay-Jensen, Suntara Cahya, Ernst R Dow, Morten A Karsdal, Alisa E Koch, Wenling Zhang, Robert J Benschop
Reumatología Clinica
Daniel Rivas-Vargas, Soham Al Snih, Martín A Rodríguez